Open-label extension trial with gantenerumab Q&A (French)

For privacy, this recording is password protected. If you are a member of a family living with DIAD, request password here »

Description: Question and answer session with Dr. Randall Bateman on August 14, 2023, on the ending of the open-label extension trial with gantenerumab.